Cadrenal Therapeutics, Inc.
CVKD
$10.63
$1.7719.98%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -14.39M | -14.11M | -12.83M | -10.65M | -7.61M |
| Total Depreciation and Amortization | 6.70K | 6.70K | 6.80K | 1.90K | 2.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | 0.00 |
| Total Other Non-Cash Items | 2.38M | 2.20M | 1.80M | 1.42M | 758.60K |
| Change in Net Operating Assets | 178.50K | 230.00K | 851.90K | 1.87M | 586.20K |
| Cash from Operations | -11.82M | -11.67M | -10.17M | -7.36M | -6.26M |
| Capital Expenditure | -11.70K | -9.80K | -9.80K | -6.50K | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -11.70K | -9.80K | -9.80K | -6.50K | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 7.68M | 8.63M | 7.31M | 5.25M | 1.64M |
| Repurchase of Common Stock | -- | -- | -- | -- | -12.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.65M | 3.58M | 3.64M | 3.73M | -107.80K |
| Cash from Financing | 11.33M | 12.21M | 10.95M | 8.98M | 1.52M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -503.80K | 533.50K | 769.60K | 1.62M | -4.75M |